HCPCS code J0461 – Atropine sulfate injection billing guide

Key takeaways

J0461 covers injectable atropine sulfate only, while eye drops and oral forms are billed differently.

One billing unit equals 0.01 mg, so a 0.4 mg dose goes on the claim as 40 units.

Medicaid and many commercial payers require the 11-digit NDC with the N4 qualifier, so check each payer’s policy.

Atropine that isn’t therapeutically equivalent to J0461 takes J0462, and J3490 is only for products with no assigned code.

Pabau, the practice platform we build, helps you submit and track J0461 claims and spot denial patterns.

HCPCS Code J0461: official descriptor and drug identity

HCPCS Code J0461 is the Centers for Medicare and Medicaid Services (CMS) Level II drug injection code for atropine sulfate. Its official descriptor is “Injection, atropine sulfate, 0.01 mg.” The code belongs to the HCPCS Level II J-series, which covers drugs administered other than by mouth that a CPT procedure code alone can’t describe.

Atropine sulfate is an anticholinergic drug. Clinicians inject it to treat symptomatic bradycardia and organophosphate poisoning, and give it with neostigmine when neuromuscular blockade is reversed after surgery. J0461 covers only the injectable formulation administered in a clinical setting.

The table below summarizes the code’s key reference data.

What J0461 covers and what it does not

J0461 covers atropine sulfate administered by injection in a clinical setting. It does not cover all clinical uses of atropine or all atropine formulations. Billing the wrong formulation under J0461 is a direct path to a denial.

• Covered: injectable atropine sulfate given intravenously, intramuscularly, or subcutaneously in a physician office, outpatient hospital, ASC, or emergency department.
• Not covered under J0461: atropine sulfate ophthalmic solution (eye drops) given topically. Eye drops are included in the procedure fee or billed with a different supply code.
• Not covered under J0461: oral atropine formulations. No J-code exists for oral drugs billed on their own.
• Falls to J0462: injectable atropine sulfate that is not therapeutically equivalent to J0461. Check the product’s NDC against the J0461/J0462 crosswalk to confirm which code applies.
• Falls to J3490: compounded or combination atropine products without an assigned code. These typically need J3490 (unclassified drugs) with supporting documentation.

When a practice compounds atropine or uses a nonstandard concentration, ask the payer whether J0461, J0462, or J3490 with an invoice applies before submitting. CMS also maintains product-specific atropine codes, such as J0463 for Fresenius products, so the NDC crosswalk is the deciding check. The diagram below works through those checks in order.

How to calculate billing units for J0461

The unit definition for J0461 is 0.01 mg of atropine sulfate per unit. Convert the administered dose in milligrams to units by dividing by 0.01, which is the same as multiplying by 100.

Rounding rule: bill only for the dose actually administered. If a single-dose vial holds 0.4 mg and 0.3 mg is given, bill 30 units on one line. Report the discarded 0.1 mg as 10 units on a second line with modifier JW. If none of the single-dose vial is wasted, add modifier JZ instead.

Medicare has required JW on discarded drug since 2017. JZ has been required on Medicare single-dose container claims since July 1, 2023, after an educational period from January to June. JW and JZ are Medicare policy, so check other payers’ rules before applying them.

The most common unit error is entering the milligram dose directly into the units field. A biller who enters “0.4” instead of “40” reports a fraction of the dose, so the line rejects or underpays. Over-counting units trips the payer’s medically unlikely edit (MUE) or a CO-151 adjustment instead.

Documentation requirements for J0461 claims

Complete documentation on the CMS-1500 form is the front line against denials. For J0461, seven data elements must be correct before submission.

• Drug name and dose: atropine sulfate with the exact milligram dose administered, recorded in the clinical note and matching the units billed.
• NDC number: where the payer requires it, the 11-digit NDC with the N4 qualifier in the shaded area of box 24. Add the unit qualifier (UN for units, ML for milliliters, GR for grams) and the NDC quantity.
• Place of service code: POS 11 (office), 22 (outpatient hospital), 23 (emergency department), or 24 (ASC) as applicable.
• Drug administration code: CPT 96372 for a subcutaneous or IM injection, or CPT 96374 for an IV push. In office settings, J0461 is normally billed with an administration code.
• Treating provider NPI: the administering clinician’s NPI in box 24J.
• Diagnosis code: an ICD-10-CM code that supports the medical necessity of atropine, such as R00.1 for bradycardia or T60.0X1A for accidental organophosphate poisoning.
• Date of service: must match the administration date in the clinical note exactly.

Following a clean claim checklist before submission catches missing elements that automated payer edits flag within seconds of receipt.

NDC reporting: format and placement

Medicaid requires the NDC on drug claims under the Deficit Reduction Act of 2005 rebate rules, and many commercial payers require it too. Medicare Part B does not require it on J0461, which has an assigned J-code and an ASP payment limit. Check payer policy before you submit.

Where an NDC is required, report the 11-digit form of the product actually given. A 10-digit package NDC needs a leading zero in the right segment to reach the 5-4-2 format.

• Format: 11 digits, no hyphens, in the shaded supplemental area of box 24 on the CMS-1500.
• Qualifier: N4 immediately before the 11-digit NDC (e.g. N412345678901).
• Unit qualifier: UN (each/unit), ML (milliliter), or GR (gram) matching the drug’s dispensed quantity.
• Source: find the NDC on the vial label or carton. It must match the product and package used, not a formulary reference NDC.

Medicare and Medicaid reimbursement for J0461

Medicare Part B pays for J0461 under the Average Sales Price (ASP) methodology set by the Medicare Modernization Act of 2003. In a physician office, the payment limit is ASP plus 6 percent. CMS updates the limits quarterly, so check the current CMS Part B ASP pricing files before estimating patient cost-sharing.

Atropine sulfate is a low-cost generic, so the ASP+6% dollar figure is small. The place of service matters more, because it decides who bills the drug at all.

Medicaid coverage is not uniform. Each state Medicaid program maintains its own drug fee schedule. Some payers, including Medicaid managed care plans, may apply PA or coverage limits, so verify with the payer. Check the state-specific Medicaid fee schedule rather than assuming federal Medicare rates apply.

Prior authorization requirements for J0461

Medicare Part B does not require prior authorization for atropine sulfate injection under standard Part B coverage. Atropine is common in emergency, cardiac, and perioperative care, where waiting for prior approval would be clinically impractical.

Other payers set their own rules, and some may apply PA or coverage limits. Verify with the payer before assuming no PA is needed:

• Medicaid managed care: individual plans may require PA for scheduled, non-emergency atropine use.
• Commercial insurers: some payers may apply PA or coverage limits outside emergency or perioperative care.
• Medicare Advantage plans: plans may apply their own PA rules or coverage limits, so check with the plan.

Running an insurance eligibility verification before the appointment surfaces PA requirements and benefit limits before the drug is administered.

J0461, J0462 or J3490: choosing the correct code

J0462 is the code for injectable atropine sulfate that is not therapeutically equivalent to J0461, billed in the same 0.01 mg units. Check the product’s NDC against the J0461/J0462 crosswalk to see which code it maps to.

J3490 is the unclassified drug code, used only when no specific HCPCS code exists for the drug administered. Because atropine has assigned codes, J3490 is almost never right for a standard injectable product. Most payers down-code or deny J3490 when a specific code exists, and the extra documentation raises audit risk.

J3490 is legitimately used for compounded atropine (e.g. atropine in a multi-drug compound without an assigned code) or for combination products. Confirm the formulation and NDC before choosing between the three codes.

Related codes and companion codes

J0461 rarely stands alone on an office claim. It is normally paired with an administration code: 96372 for a subcutaneous or intramuscular injection, or 96374 for an IV push.

The diagnosis code and any JW or JZ modifier complete the line. Building these companion codes into your superbill template keeps the administration code from being left off.

Common J0461 claim denial reasons and how to fix them

Most J0461 denials fall into five categories. Each one has a specific root cause and a targeted corrective action. Compare your denial management workflow against this list to see which errors your practice encounters most often.

The full denial code reference covers CARC and RARC combinations for drug claims, helping billers tell payer error from practice error on remittance advice. Tracking these denial patterns monthly shows whether a denial is a one-off entry mistake or a recurring workflow problem.

How Pabau helps you submit and track J0461 claims

The denials above usually start at charge entry, where someone converts the dose by hand and copies the NDC off the vial. A charge entry template that spells out the unit math and NDC steps cuts those errors before the claim leaves the practice.

Pabau, the practice platform we build, includes claims software for practices. It helps you submit and track J0461 claims and spot denial patterns. Your team still owns these steps:

1. Create the charge entry: select J0461 and confirm the descriptor matches the product given.
2. Enter the units: convert the milligram dose with the 0.01 mg formula before you save the charge.
3. Add the NDC where the payer requires it: enter the 11-digit NDC with the N4 qualifier and the unit qualifier.
4. Pair the administration code: add CPT 96372 or 96374 to the same encounter before you finalize the claim.
5. Check payer rules: confirm eligibility and any PA requirement for the patient’s plan before the drug is given.

Once a claim goes out, Pabau tracks its status and remittance. A repeat CO-16 or CO-151 on J0461 then shows up as a pattern, so you can fix the template before the next batch.

Submit and track J0461 claims in one place

Pabau helps practices submit and track J0461 claims and spot denial patterns, so unit and NDC errors get fixed at the source.

Book a demo

Conclusion

J0461 is a straightforward code once the unit formula, the payer’s NDC rule, and the administration code are built into charge entry. The denials that cost practices money on atropine claims are almost always preventable.

The trade-off is upkeep. Your charge template and NDC reference sheet need updating whenever the crosswalk changes or the practice switches supplier. Skip that, and yesterday’s clean claim becomes today’s CO-16.

Pabau helps you submit and track J0461 claims and spot denial patterns, so your team fixes causes instead of reworking claims. Book a demo to see how it fits your drug billing workflow.

Continue your research

Need a complete medical billing reference? What is medical billing walks through the full revenue cycle from charge capture to payment posting.

Tracking denials across your drug claims? Denial management in healthcare covers how to categorize, appeal, and reduce claim rejection rates systematically.

Want a clean claim framework for every submission? Clean claim best practices outlines the pre-submission checks that keep drug claims out of the denial queue.

Frequently asked questions